Tower Research Capital LLC TRC Takes $397,000 Position in Core Laboratories (CLB)

Tower Research Capital LLC TRC bought a new position in Core Laboratories (NYSE:CLB) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,621 shares of the oil and gas company’s stock, valued at approximately $397,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Robeco Institutional Asset Management B.V. grew its stake in shares of Core Laboratories by 60.7% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 1,096 shares of the oil and gas company’s stock worth $120,000 after purchasing an additional 414 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of Core Laboratories by 63.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock worth $114,000 after purchasing an additional 439 shares during the last quarter. Advisory Services Network LLC boosted its position in Core Laboratories by 33.3% during the 2nd quarter. Advisory Services Network LLC now owns 1,365 shares of the oil and gas company’s stock valued at $138,000 after acquiring an additional 341 shares in the last quarter. Callahan Advisors LLC bought a new stake in Core Laboratories during the 4th quarter valued at approximately $201,000. Finally, Toronto Dominion Bank boosted its position in Core Laboratories by 243.6% during the 3rd quarter. Toronto Dominion Bank now owns 1,866 shares of the oil and gas company’s stock valued at $184,000 after acquiring an additional 1,323 shares in the last quarter.

Several analysts have weighed in on the company. ABN Amro cut Core Laboratories from a “buy” rating to a “hold” rating in a research report on Tuesday, January 9th. Royal Bank of Canada set a $125.00 price objective on Core Laboratories and gave the company a “buy” rating in a research report on Tuesday, January 30th. Deutsche Bank cut Core Laboratories from a “buy” rating to a “hold” rating and cut their price objective for the company from $116.30 to $109.00 in a research report on Thursday, January 11th. Zacks Investment Research cut Core Laboratories from a “hold” rating to a “sell” rating in a research report on Monday, February 5th. Finally, TheStreet raised Core Laboratories from a “c” rating to a “b-” rating in a research report on Thursday, February 1st. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $111.70.

Core Laboratories (NYSE:CLB) opened at $107.33 on Friday. Core Laboratories has a 1-year low of $86.55 and a 1-year high of $121.39. The stock has a market cap of $4,616.94, a P/E ratio of 57.09 and a beta of 1.44. The company has a current ratio of 1.98, a quick ratio of 1.66 and a debt-to-equity ratio of 1.53.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, January 31st. The oil and gas company reported $0.58 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.58. Core Laboratories had a net margin of 12.60% and a return on equity of 58.25%. The firm had revenue of $172.00 million during the quarter, compared to analyst estimates of $171.92 million. During the same period last year, the business earned $0.41 earnings per share. The business’s revenue was up 15.1% on a year-over-year basis. sell-side analysts predict that Core Laboratories will post 2.66 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, February 16th. Stockholders of record on Friday, January 26th were issued a dividend of $0.55 per share. The ex-dividend date was Thursday, January 25th. This represents a $2.20 annualized dividend and a dividend yield of 2.05%. Core Laboratories’s payout ratio is 117.02%.

ILLEGAL ACTIVITY NOTICE: “Tower Research Capital LLC TRC Takes $397,000 Position in Core Laboratories (CLB)” was originally reported by BBNS and is the property of of BBNS. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://baseballnewssource.com/markets/tower-research-capital-llc-trc-takes-397000-position-in-core-laboratories-clb/1911203.html.

About Core Laboratories

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish


Leave a Reply

 
© 2006-2018 BBNS.